Bringing an aerosol drug to market quickly and cost-effectively takes a successful combination of clinical efficacy, testing accuracy and regulatory expertise. Philips advanced aerosol devices and lab facilities offer pharmaceutical companies an in-depth level of support from every step of the development process - from pre-test to market.
With a singular focus on device technology, our priority is your drug. We offer a range of devices and drug delivery technologies - developed through nearly 40 years of innovation - giving you flexibility to meet both your clinical and financial requirements. If your drug requires unique features or functions, we can work with you to create a custom device to meet your needs.
Our own state-of-the-art, regulatory compliant R&D and lab facilities deliver comprehensive drug and device testing in clinical performance, drug delivery integrity, and data generation for trials and submission.
When your product is ready for submission, our team brings deep knowledge of both the drug and delivery regulatory processes, and can help identify the optimal approach. And with a global manufacturing footprint, we have the ability to scale to meet your continued commercial success.
